237 related articles for article (PubMed ID: 33348308)
21. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
22. The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis.
Magnusson MK; Isaksson S; Öhman L
Inflammation; 2020 Apr; 43(2):507-517. PubMed ID: 31797122
[TBL] [Abstract][Full Text] [Related]
23. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
Gan H; Ouyang Q; Chen Y; Xia Q
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
[TBL] [Abstract][Full Text] [Related]
24. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis.
Li H; Feng C; Fan C; Yang Y; Yang X; Lu H; Lu Q; Zhu F; Xiang C; Zhang Z; He P; Zuo J; Tang W
Cell Death Dis; 2020 Apr; 11(4):271. PubMed ID: 32332711
[TBL] [Abstract][Full Text] [Related]
25. Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway.
Qiu S; Li P; Zhao H; Li X
Int Immunopharmacol; 2020 Jan; 78():106018. PubMed ID: 31780371
[TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.
Messal N; Fernandez N; Dayot S; Gratio V; Nicole P; Prochasson C; Chantret I; LeGuilloux G; Jarry A; Couvelard A; Tréton X; Voisin T; Ogier-Denis E; Couvineau A
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3618-3628. PubMed ID: 30251681
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.
Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616
[TBL] [Abstract][Full Text] [Related]
28. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer.
Landy J; Ronde E; English N; Clark SK; Hart AL; Knight SC; Ciclitira PJ; Al-Hassi HO
World J Gastroenterol; 2016 Mar; 22(11):3117-26. PubMed ID: 27003989
[TBL] [Abstract][Full Text] [Related]
29. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
[TBL] [Abstract][Full Text] [Related]
30. Effects of Alpinetin on Intestinal Barrier Function, Inflammation and Oxidative Stress in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice.
Tan Y; Zheng C
Am J Med Sci; 2018 Apr; 355(4):377-386. PubMed ID: 29661352
[TBL] [Abstract][Full Text] [Related]
31. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
32. Administration of geniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage.
Zhang Z; Li Y; Shen P; Li S; Lu X; Liu J; Cao Y; Liu B; Fu Y; Zhang N
Int Immunopharmacol; 2017 Aug; 49():168-177. PubMed ID: 28595080
[TBL] [Abstract][Full Text] [Related]
33. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids.
Nishimura R; Shirasaki T; Tsuchiya K; Miyake Y; Watanabe Y; Hibiya S; Watanabe S; Nakamura T; Watanabe M
J Gastroenterol; 2019 Jul; 54(7):608-620. PubMed ID: 30599053
[TBL] [Abstract][Full Text] [Related]
35. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
36. Th9 Cells: Probable players in ulcerative colitis pathogenesis.
Shohan M; Elahi S; Shirzad H; Rafieian-Kopaei M; Bagheri N; Soltani E
Int Rev Immunol; 2018; 37(4):192-205. PubMed ID: 29672174
[TBL] [Abstract][Full Text] [Related]
37. D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways.
Yu L; Yan J; Sun Z
Mol Med Rep; 2017 Apr; 15(4):2339-2346. PubMed ID: 28260017
[TBL] [Abstract][Full Text] [Related]
38. Systems pharmacology approach reveals the antiinflammatory effects of
Chen YL; Zhang YL; Dai YC; Tang ZP
World J Gastroenterol; 2018 Apr; 24(13):1398-1409. PubMed ID: 29632421
[TBL] [Abstract][Full Text] [Related]
39. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
40. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
